PPFIA4 promotes castration-resistant prostate cancer by enhancing mitochondrial metabolism through MTHFD2

BACKGROUND: The development of castration-resistant prostate cancer (CRPC) remains a major obstacle in the treatment of prostate cancer (PCa). Dysregulated mitochondrial function has been linked to the initiation and progression of diverse human cancers. Deciphering the novel molecular mechanisms un...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ru, Feng, Tingting, Gao, Lin, Sun, Feifei, Zhou, Qianqian, Wang, Xin, Liu, Junmei, Zhang, Wenbo, Wang, Meng, Xiong, Xueting, Jia, Wenqiao, Chen, Weiwen, Wang, Lin, Han, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985307/
https://www.ncbi.nlm.nih.gov/pubmed/35382861
http://dx.doi.org/10.1186/s13046-022-02331-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985307/
https://www.ncbi.nlm.nih.gov/pubmed/35382861
http://dx.doi.org/10.1186/s13046-022-02331-3

Ejemplares similares